There are 2137 resources available
1820P - Taxane-related skin toxicity: Analysis of an in vivo and 3D in vitro model study of the impact of paclitaxel on skin
Presenter: Martin Perez-Leal
Session: E-Poster Display
Resources:
Abstract
1821P - A multicentre analysis of toxicity in 6 weekly vs 3 weekly pembrolizumab dosing
Presenter: Michael Rowe
Session: E-Poster Display
Resources:
Abstract
1822P - Impact of iron-deficiency management on quality of life in cancer patients: A prospective cohort study (CAMARA study)
Presenter: Cassandre Gluszak
Session: E-Poster Display
Resources:
Abstract
1823P - Characterization of thrombosis risk in patients with cancer: Preliminary results
Presenter: Pablo Cerezuela
Session: E-Poster Display
Resources:
Abstract
1824P - Incidence, risk factors and clinical outcome of venous and arterial thromboembolism in patients treated with immune-checkpoint inhibitors
Presenter: Florian Moik
Session: E-Poster Display
Resources:
Abstract
1825P - Prevention and prophylaxis (thromboprophylaxis - ACT) of cancer associated thrombosis (CAT) in high risk oncology patients: ACT4CAT
Presenter: Nikolaos Tsoukalas
Session: E-Poster Display
Resources:
Abstract
1826P - Thrombosis incidence in cancer patients treated with antiangiogenic therapy
Presenter: Magda Palka Kotlowska
Session: E-Poster Display
Resources:
Abstract
1827P - Evaluation of oral hemorrhage following dental extractions in patients receiving bevacizumab
Presenter: Hanane Ammar Boudjelal
Session: E-Poster Display
Resources:
Abstract
1828P - Effect of serum albumin/globulin ratio in combination with MASCC and CISNE risk score on febrile neutropenia mortality
Presenter: Ozan Yazıcı
Session: E-Poster Display
Resources:
Abstract
1829P - Are patient-reported symptoms and concerns affected by body mass index (BMI) and weight loss (WL) in patients with cancer cachexia?
Presenter: Stein Kaasa
Session: E-Poster Display
Resources:
Abstract